ANI Pharmaceuticals | ANIP - Equity Capital And Reserves

Stock Price
81.50
Daily Change
0.23 0.28%
Monthly
5.19%
Yearly
35.40%
Q1 Forecast
79.33

ANI Pharmaceuticals reported $505.82M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -2.64B 2.46B Sep/2025
ANI Pharmaceuticals USD 505.82M 69.06M Sep/2025
Aurora Cannabis CAD 567.1M 21.58M Sep/2025
Canopy Growth CAD 736.01M 247.04M Sep/2025
Eli Lilly USD 23.79B 5.52B Sep/2025
Hikma Pharmaceutical USD 2.55B 230M Jun/2025
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Novartis USD 44.33B 2.28B Sep/2025
Perrigo USD 4.45B 25.8M Sep/2025
Sun Pharmaceuticals INR 778.2B 56.02B Sep/2025
Teva Pharmaceutical Industries USD 7.91B 664M Dec/2025